Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.

@article{Wu2005GraftversusleukemiaTA,
  title={Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.},
  author={Catherine J. Wu and Melinda A Biernacki and Jeffery L. Kutok and Shelby A Rogers and Linyun Chen and Xiaofeng Yang and Robert J. Soiffer and Jerome Ritz},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2005},
  volume={11 12},
  pages={4504-11}
}
PURPOSE Donor lymphocyte infusion (DLI) reliably induces durable remission in 75% to 80% of patients with relapsed chronic myelogenous leukemia (CML) following allogeneic bone marrow transplantation. We previously reported the identification of a high titer-specific immunoglobulin G response against two novel leukemia-associated antigens, CML28 and CML66, which correlated with immune-induced remission. The present studies characterize expression of CML28 and CML66 in primary hematopoietic… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

BAFF and rheumatic autoimmune disorders: implications for disease management and therapy.

International journal of immunopathology and pharmacology • 2007
View 11 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…